InTest (INTT) Q2 2026 Earnings Call Transcript

InTest reported Q2 revenue of $35.3M (+25.5% YoY) and raised full-year revenue guidance to $135M–$140M (~21% growth at the midpoint). Orders were resilient—semi orders rose 64% YoY and backlog increased 19.8% YoY to $45.4M—with management citing recovering back-end semiconductor testing demand. However, gross margin fell 210 bps YoY to 40.5% on an unfavorable mix, and the company disclosed Alfamation control deficiencies constituting a material weakness in internal control over financial reporting. Liquidity remained solid with $22.1M cash and $62M total liquidity against $6.2M debt (0.8x leverage).

Analysis

INTT is becoming a cleaner way to express a back-end semiconductor upcycle, but the stock is not yet a clean fundamental compounder. The near-term earnings lever is mix: if semi revenue converts from orders into shipments over the next 1-2 quarters, gross margin should re-rate upward and offset the still-lumpy Auto/EV and defense streams; if it does not, the business is left with project noise and limited visibility.

The real constraint is credibility, not leverage. A material weakness in one operating unit tends to cap multiples in small industrials until investors see at least one clean reporting cycle and evidence that remediation sticks; that matters more here than the small debt load or decent liquidity. In other words, the balance sheet reduces blow-up risk, but it does not remove the discount for execution risk.

Contrarian view: the market may be over-optimistic about duration. The semi commentary implies a finite 6-12 month capacity window, so this can easily be a short, sharp order burst rather than the start of a multi-year reacceleration. The bull case is a few quarters of margin expansion and cleaner guidance; the bear case is that this quarter front-loads backlog and the growth rate fades before the multiple can expand materially.

Key Decisions for Investors

• Tactical long INTT only on post-earnings weakness, sized small: thesis is 1-2 quarters of semi-driven margin expansion and improving credibility; fade the position if gross margin cannot hold the low-40s while orders remain volatile.
• Pair trade: long INTT / short SOXX for a 1-3 month relative-value expression on idiosyncratic execution rather than pure semiconductor beta; this works only if INTT’s semi mix translates into margin outperformance.
• If already long, sell near-dated calls against the position into the current strength; upside is likely more multiple-credibility driven than estimate-revision driven, so theta can be monetized while waiting for controls to be proven.
• Set a hard watch item on the next filing: if remediation language weakens or a second control issue appears, exit the trade immediately; that would likely re-open the valuation discount even if revenue is fine.